Fixing common blood disorder would make kidney transplants more successful

December 22, 2011

Washington, DC (December 22, 2011) -- Correcting anemia, a red blood cell deficiency, can preserve kidney function in many kidney transplant recipients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results indicate that aggressively treating anemia may help save the kidneys--and possibly the lives--of many transplant recipients.

Anemia commonly arises in patients with kidney disease because the kidneys secrete most of the hormone erythropoietin that stimulates red blood cell production. Anemia is also a common complication of kidney transplantation, with a prevalence of 25% to 40% after the first year.

Gabriel Choukroun, MD, PhD (CHU Amiens in France) and his colleagues initiated the Correction of Anemia and PRogression of Renal Insufficiency in Transplant patients (CAPRIT) study to see if the drug epoetin beta (a synthetic form of erythropoietin) could help preserve kidney function in kidney transplant recipients with anemia. Specifically, the investigators tested whether completely correcting anemia (by normalizing levels of hemoglobin, a blood component that carries oxygen) is better than partially correcting anemia.

During the study, 63 kidney transplant recipients took epoetin beta so that their hemoglobin levels remained in the normal range of 13.0 to 15.0 g/dL, while 62 patients took epoetin beta so that their hemoglobin levels hovered at a lower concentration of 10.5 to 11.5 g/dL.

Among the major findings after patients were treated for two years: "This study shows that correction of anemia in kidney transplant recipients with anemia slows the progression of kidney failure and improves survival of transplanted kidneys," said Dr. Choukroun. Additional studies are needed to determine whether this also prolongs patients' lives.
-end-
Study co-authors include Nassim Kamar, Lionel Rostaing (CHU Toulouse); Bertrand Dussol (CHU Marseille); Isabelle Etienne (CHU Rouen); Elisabeth Cassuto-Viguier (CHU Nice); Olivier Toupance (CHU Reims); François Glowacki (CHU Lille); Bruno Moulin (CHU Strasbourg); Yvon Lebranchu (CHU Tours); Guy Touchard (CHU Poitiers); Maïté Jaureguy (CHU Amiens); Nicolas Pallet, Frank Martinez (CHU Necker); and Yannick Le Meur (CHU Brest).

Disclosures: The study was funded in part by a grant from Roche. Dr. Choukroun received honorarium from Roche for lectures and a grant for clinical research.

The article, entitled "Correction of Post-Kidney Transplant Anemia Reduces Progression of Allograft Nephropathy," will appear online at http://jasn.asnjournals.org/ on December 22, 2011, doi: 10.1681/ASN.2011060546.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with more than 13,500 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.

American Society of Nephrology

Related Anemia Articles from Brightsurf:

Study explores the association of malaria, HIV with anemia during pregnancy
Pregnant women from sub-Saharan Africa with malaria and human immunodeficiency virus (HIV) have a higher prevalence of anemia than pregnant women without infections, according to Penn State College of Medicine researchers.

Women with anemia twice as likely to need transfusion after cesarean delivery
Pregnant women with anemia are twice as likely to need blood transfusions after a cesarean delivery, as those without the condition, according to a study being presented at the ANESTHESIOLOGY® 2019 annual meeting.

Early maternal anemia tied to intellectual disability, ADHD and autism
The timing of anemia -- a common condition in late pregnancy -- can make a big difference for the developing fetus, according to research at Karolinska Institutet published in JAMA Psychiatry.

Anemia may contribute to the spread of dengue fever
Mosquitoes are more likely to acquire the dengue virus when they feed on blood with low levels of iron, researchers report in the 16 September issue of Nature Microbiology.

No bleeding required: Anemia detection via smartphone
Instead of a blood test, an app uses smartphone photos of someone's fingernails to accurately measure hemoglobin levels.

Malnutrition, anemia among Rohingya children in Bangladesh refugee camp
The pervasiveness of malnutrition and anemia among Rohingya children in a refugee camp in Bangladesh exceeds emergency thresholds.

Anemia: When cells fail to produce enough protein factories
Every day, stem cells in our bone marrow produce billions of new red blood cells.

Anemia discovery offers new targets to treat fatigue in millions
UVA has discovered an unknown biological process that controls the production of vital cells that carry oxygen throughout the body.

Fanconi anemia: Insight from a green plant
Fanconi anemia is a human genetic disorder with severe effects, including an increased risk of cancer and infertility.

New portable blood analyzer could improve anemia detection worldwide
To reduce the burden of anemia, health officials need a better picture of the disease's global impact, an understanding made viable by a portable and affordable way to analyze blood.

Read More: Anemia News and Anemia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.